Författarna: |
Kim YY; Genetics Branch, NCI, NIH, Bethesda, MD, USA. yong.kim@nih.gov., Gryder BE; Genetics Branch, NCI, NIH, Bethesda, MD, USA.; Department of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, OH, USA., Sinniah R; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Peach ML; Basic Science Program, Frederick National Laboratory for Cancer Research (FNLCR), Frederick, MD, USA., Shern JF; Pediatric Oncology Branch, NCI, NIH, Bethesda, MD, USA., Abdelmaksoud A; Collaborative Bioinformatics Resource, NCI, NIH, Bethesda, MD, USA., Pomella S; Genetics Branch, NCI, NIH, Bethesda, MD, USA.; Department of Hematology and Oncology, Cell and Gene Therapy, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy., Woldemichael GM; Leidos Biomed Res Inc, FNLCR, Basic Sci Program, Frederick, MD, USA.; Molecular Targets Program, NCI, NIH, Frederick, MD, USA., Stanton BZ; Genetics Branch, NCI, NIH, Bethesda, MD, USA.; Nationwide Children's Hospital, Center for Childhood Cancer Research, Columbus, OH, USA.; Department of Pediatrics, The Ohio State University College of Medicine, Columbus, OH, USA.; Department of Biological Chemistry & Pharmacology, The Ohio State University College of Medicine, Columbus, OH, USA., Milewski D; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Barchi JJ Jr; Chemical Biology Laboratory, NCI, NIH, Frederick, MD, USA., Schneekloth JS Jr; Chemical Biology Laboratory, NCI, NIH, Frederick, MD, USA., Chari R; Genome Modification Core, Laboratory Animal Sciences Program, FNLCR, Frederick, MD, USA., Kowalczyk JT; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Shenoy SR; Leidos Biomed Res Inc, FNLCR, Basic Sci Program, Frederick, MD, USA.; Molecular Targets Program, NCI, NIH, Frederick, MD, USA., Evans JR; Natural Products Branch, NCI, NIH, Frederick, MD, USA., Song YK; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Wang C; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Wen X; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Chou HC; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Gangalapudi V; Genetics Branch, NCI, NIH, Bethesda, MD, USA., Esposito D; Protein Expression Laboratory, FNLCR, NIH, Frederick, MD, USA., Jones J; Protein Expression Laboratory, FNLCR, NIH, Frederick, MD, USA., Procter L; Protein Expression Laboratory, FNLCR, NIH, Frederick, MD, USA., O'Neill M; Protein Characterization Laboratory, FNLCR, NIH, Frederick, MD, USA., Jenkins LM; Laboratory of Cell Biology, NCI, NIH, Bethesda, MD, USA., Tarasova NI; Cancer Innovation Laboratory, NCI, NIH, Bethesda, MD, USA., Wei JS; Genetics Branch, NCI, NIH, Bethesda, MD, USA., McMahon JB; Molecular Targets Program, NCI, NIH, Frederick, MD, USA., O'Keefe BR; Molecular Targets Program, NCI, NIH, Frederick, MD, USA.; Natural Products Branch, NCI, NIH, Frederick, MD, USA., Hawley RG; Genetics Branch, NCI, NIH, Bethesda, MD, USA.; Department of Anatomy and Cell Biology, George Washington University, Washington, DC, USA., Khan J; Genetics Branch, NCI, NIH, Bethesda, MD, USA. khanjav@mail.nih.gov. |
Språk: |
English |
References: |
Nucleic Acids Res. 2020 Jul 2;48(W1):W177-W184. (PMID: 32301980) Cancer Discov. 2017 Aug;7(8):884-899. (PMID: 28446439) Mol Oncol. 2012 Dec;6(6):683-703. (PMID: 22902149) J Med Chem. 2013 Jan 24;56(2):547-55. (PMID: 23234607) Genome Res. 2017 Nov;27(11):1939-1949. (PMID: 28855260) Nature. 2005 Sep 15;437(7057):436-9. (PMID: 16079795) Mol Cancer Ther. 2018 Sep;17(9):1902-1916. (PMID: 29997151) Nat Genet. 2003 Jul;34(3):267-73. (PMID: 12808457) Nat Genet. 2020 Nov;52(11):1247-1255. (PMID: 33077914) Cancer Res. 2008 May 15;68(10):3767-76. (PMID: 18483260) Crit Rev Oncog. 2015;20(3-4):227-43. (PMID: 26349418) Biochem Biophys Res Commun. 2019 Jan 8;508(2):576-582. (PMID: 30514438) Nat Genet. 2019 Dec;51(12):1714-1722. (PMID: 31784732) Sci Transl Med. 2018 Jul 4;10(448):. (PMID: 29973406) Cell. 2018 May 17;173(5):1165-1178.e20. (PMID: 29706548) Cancers (Basel). 2021 Apr 06;13(7):. (PMID: 33917420) Nat Biotechnol. 2007 Feb;25(2):197-206. (PMID: 17287757) Nature. 2012 Jan 04;481(7381):389-93. (PMID: 22217937) Cell Syst. 2016 Jul;3(1):95-8. (PMID: 27467249) Dev Cell. 2022 May 23;57(10):1226-1240.e8. (PMID: 35483358) Methods Enzymol. 2019;623:131-149. (PMID: 31239044) Nat Genet. 2000 May;25(1):25-9. (PMID: 10802651) Cell Death Dis. 2017 Jun 15;8(6):e2879. (PMID: 28617441) Cancer Res. 1988 Feb 1;48(3):589-601. (PMID: 3335022) Nat Commun. 2018 Dec 21;9(1):5416. (PMID: 30575746) Genome Biol. 2014;15(12):554. (PMID: 25476604) J Biomol NMR. 2000 Sep;18(1):65-8. (PMID: 11061229) Curr Protoc. 2021 Mar;1(3):e90. (PMID: 33780170) Cell Syst. 2015 Dec 23;1(6):417-425. (PMID: 26771021) Nat Biotechnol. 2018 Dec 03;:. (PMID: 30531897) Nat Commun. 2019 Jul 8;10(1):3004. (PMID: 31285436) Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50. (PMID: 16199517) J Clin Oncol. 2002 Jun 1;20(11):2672-9. (PMID: 12039929) Cancer Discov. 2014 Feb;4(2):216-31. (PMID: 24436047) Mol Cell. 2010 May 28;38(4):576-89. (PMID: 20513432) Nat Methods. 2012 Feb 28;9(3):215-6. (PMID: 22373907) Cell. 2015 Dec 3;163(6):1515-26. (PMID: 26627737) Cell Rep. 2017 May 23;19(8):1669-1684. (PMID: 28538184) Mod Pathol. 2021 Apr;34(4):748-757. (PMID: 33299109) Nature. 2018 Mar 15;555(7696):321-327. (PMID: 29489754) Nucleic Acids Res. 2014 Jul;42(Web Server issue):W187-91. (PMID: 24799436) Sci Rep. 2019 Mar 26;9(1):5233. (PMID: 30914743) Mol Cell Biol. 2012 Jul;32(14):2917-33. (PMID: 22615488) iScience. 2021 Jul 16;24(8):102867. (PMID: 34386729) Cell. 2019 Jun 13;177(7):1888-1902.e21. (PMID: 31178118) Bioinformatics. 2010 Mar 15;26(6):841-2. (PMID: 20110278) Int J Cancer. 2020 Jan 15;146(2):400-412. (PMID: 31271662) Am J Surg Pathol. 2007 Jun;31(6):895-901. (PMID: 17527077) Sci Transl Med. 2022 Jul 13;14(653):eabq2096. (PMID: 35857643) Genome Biol. 2020 Dec 17;21(1):303. (PMID: 33334380) Oncogene. 2007 Nov 8;26(51):7267-81. (PMID: 17525748) Nat Commun. 2013;4:2035. (PMID: 23792809) |
Grant Information: |
HHSN261200800001C United States RC CCR NIH HHS; HHSN261200800001E United States CA NCI NIH HHS |
Substance Nomenclature: |
0 (Paired Box Transcription Factors) 0 (Forkhead Box Protein O1) 0 (Oncogene Proteins, Fusion) 0 (PAX3 Transcription Factor) 0 (FOXO1 protein, human) EC 1.14.11.- (KDM3B protein, human) EC 1.14.11.- (Jumonji Domain-Containing Histone Demethylases) 0 (PAX3 protein, human) EC 1.5.- (KDM1A protein, human) EC 1.14.11.- (Histone Demethylases) |
PubMed Central ID: |
PMC10894237 |
PMID: |
38402212 |
|